1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceutical Analysis & Statistics in Oceania Countries, June 2014 (p4)

Pharmaceutical Analysis & Statistics in Oceania Countries, June 2014 (p4)

91-120 of about 200 reports

Purchase Reports From Reputable Market Research Publishers

QRxPharma Limited - Product Pipeline Review - 2014

QRxPharma Limited - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • June 2014
  • by Global Markets Direct

QRxPharma Limited - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘QRxPharma Limited - Product Pipeline Review - 2014’, provides an overview of the QRxPharma Limited’s pharmaceutical ...

  • Industries : Drug and Medication
  • Countries : China, World, Australia
Global Skincare Market: Merger and Acquisitions May 2014

Global Skincare Market: Merger and Acquisitions May 2014

  • $ 295
  • Industry report
  • June 2014
  • by Canadean Ltd

Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global skincare market during May 2014. Summary Using ...

  • Industries : Skin Care
  • Countries : United States, New Zealand, World
Physiotherapy Services in Australia - Industry Market Research Report

Physiotherapy Services in Australia - Industry Market Research Report

  • $ 965
  • Industry report
  • June 2014
  • by Ibisworld

Picture of health: An ageing population and specialisation trends support revenue growth Physiotherapy Services in Australia This industry is made up of companies and practitioners that primarily provide ...

  • Industries : Therapy
  • Countries : Australia
Sigma Pharmaceuticals Ltd in Retailing (Australia)

Sigma Pharmaceuticals Ltd in Retailing (Australia)

  • $ 143
  • Company report
  • June 2014
  • by Euromonitor International

After a successful redefinition of its business strategy, Sigma Pharmaceuticals has been focusing on strengthening its pharmacy-based retail business. In the first quarter of 2013, Sigma Pharmaceuticals ...

  • Industries : Pharmaceutical
  • Countries : Australia
PharmaPoint: Major Depressive Disorder - Australia Drug Forecast and Market Analysis to 2023

PharmaPoint: Major Depressive Disorder - Australia Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • May 2014
  • by Global Data

PharmaPoint: Major Depressive Disorder - Australia Drug Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market ...

  • Industries : Drug and Medication
  • Countries : Australia
Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Drug and Medication
  • Countries : World, Australia
Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Drug and Medication, Pathology
  • Countries : World, Australia
Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Drug and Medication, Pathology
  • Countries : World, Australia, Japan
Pristiq (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Pristiq (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Pristiq (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Drug and Medication
  • Countries : World, Australia
Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : World, Australia
Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology, Drug and Medication
  • Countries : World, Australia, Japan
Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology, Drug and Medication
  • Countries : Australia, World
Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology, Pharmaceutical
  • Countries : World, Australia
Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : World, Australia
ALKS-5461 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

ALKS-5461 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

ALKS-5461 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : World, Australia
Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : World, Australia
GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : World, Australia
Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : World, Australia
ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology, Drug and Medication
  • Countries : World, Australia
Australia Cardiac Rhythm Management Market Outlook to 2020

Australia Cardiac Rhythm Management Market Outlook to 2020

  • $ 2 500
  • Industry report
  • May 2014
  • by Global Data

Australia Cardiac Rhythm Management Market Outlook to 2020 Summary GlobalData’s new report, "Australia Cardiac Rhythm Management Market Outlook to 2020", provides key market data on the Australia Cardiac ...

  • Industries : Cardiovascular Devices
  • Countries : Australia
New Zealand Pharmaceuticals Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

New Zealand Pharmaceuticals Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary New Zealand Pharmaceuticals Ltd. (NZ Pharma) is a biotechnology service provider. The company extracts and purifies biochemicals from by-products of the New Zealand meat processing industry. Its ...

  • Industries : Pharmaceutical
  • Countries : New Zealand
Phosphagenics Limited : Ingredients - Company Profile, SWOT and Financial Report

Phosphagenics Limited : Ingredients - Company Profile, SWOT and Financial Report

  • $ 125
  • Company report
  • May 2014
  • by Canadean Ltd

Synopsis Canadean's "Phosphagenics Limited : Ingredients - Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains a ...

  • Industries : Drug and Medication
  • Countries : Australia, Japan
New Zealand Pharmaceuticals and Healthcare Report Q3 2014

New Zealand Pharmaceuticals and Healthcare Report Q3 2014

  • $ 1 300
  • Industry report
  • May 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The attractiveness of New Zealand's pharmaceutical market remains highly dependent on the decisions made by the Pharmaceutical Management Agency (PHARMAC). ...

  • Industries : Pharmaceutical, Drug and Medication, Healthcare
  • Countries : New Zealand
Pharmaceuticals in New Zealand

Pharmaceuticals in New Zealand

  • $ 350
  • Industry report
  • April 2014
  • by MarketLine

Introduction Pharmaceuticals in New Zealand industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). ...

  • Industries : Pharmaceutical, Drug and Medication, Pathology
  • Countries : New Zealand
Swisse Vitamins Pty Ltd in Consumer Health (Australia)

Swisse Vitamins Pty Ltd in Consumer Health (Australia)

  • $ 114
  • Company report
  • April 2014
  • by Euromonitor International

Swisse Vitamins Pty Ltd looks to continue its rapid expansion through focusing on international markets and continuing its strategy of engaging high profile brand ambassadors. Swisse has already ventured ...

  • Industries : Vitamin and Supplement, Vitamin and Supplement
  • Countries : Australia
Ego Pharmaceuticals Pty Ltd in Consumer Health (Australia)

Ego Pharmaceuticals Pty Ltd in Consumer Health (Australia)

  • $ 114
  • Company report
  • April 2014
  • by Euromonitor International

Ego Pharmaceuticals will continue to reinforce its dominant position in Australia while focusing on expansion within the Asia-Pacific region, the Middle East and the UK to drive additional value growth. ...

  • Industries : Pharmaceutical
  • Countries : Australia
Australia Pharmaceuticals and Healthcare Report Q3 2014

Australia Pharmaceuticals and Healthcare Report Q3 2014

  • $ 1 300
  • Industry report
  • April 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Pharmaceutical firms can expect swifter access to the Australian pharmaceutical market, following the scrapping of the Pharmaceutical Benefits Pricing Authority. ...

  • Industries : Pharmaceutical, Drug and Medication
  • Countries : Australia
Pharmaceuticals in Australia

Pharmaceuticals in Australia

  • $ 350
  • Industry report
  • April 2014
  • by MarketLine

Introduction Pharmaceuticals in Australia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). ...

  • Industries : Pharmaceutical, Drug and Medication, Pathology
  • Countries : Australia
Australia Diagnostic Imaging Market Outlook to 2020

Australia Diagnostic Imaging Market Outlook to 2020

  • $ 9 995
  • Industry report
  • March 2014
  • by Global Data

Australia Diagnostic Imaging Market Outlook to 2020 Summary GlobalData’s new report, "Australia Diagnostic Imaging Market Outlook to 2020", provides key market data on the Australia Diagnostic Imaging ...

  • Industries : Medical Imaging, Medical Imaging, Diagnostics, Diagnostics
  • Countries : Australia, Oceania
Australia Contrast Media Injectors Market Outlook to 2020

Australia Contrast Media Injectors Market Outlook to 2020

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

Australia Contrast Media Injectors Market Outlook to 2020 Summary GlobalData’s new report, "Australia Contrast Media Injectors Market Outlook to 2020", provides key market data on the Australia Contrast ...

  • Industries : Medical Imaging, Medical Imaging, Drug Delivery Technology, Diagnostics, Diagnostics
  • Countries : Australia

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.